1 Short Bowel Syndrome (SBS) Drugs Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
1.2 Short Bowel Syndrome (SBS) Drugs Segment by Type
1.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Glucagon-Like Peptide-2 (GLP-2)
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Short Bowel Syndrome (SBS) Drugs Segment by Sale Channel
1.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Comparison by Sale Channel: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2017-2028
1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2017-2028
1.4.3 Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers
2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
2.5.1 Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue
2.5.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario by Region
3.1 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
3.3.2 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.4.1 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
3.4.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region
3.5.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.6.1 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country
3.6.2 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
3.7.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Type
4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2017-2022)
4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2017-2022)
5 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Sale Channel
5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2017-2022)
5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Emmaus Medical
6.3.1 Emmaus Medical Corporation Information
6.3.2 Emmaus Medical Description and Business Overview
6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.3.5 Emmaus Medical Recent Developments/Updates
6.4 Ardelyx
6.4.1 Ardelyx Corporation Information
6.4.2 Ardelyx Description and Business Overview
6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.4.5 Ardelyx Recent Developments/Updates
6.5 Naia Pharmaceuticals
6.5.1 Naia Pharmaceuticals Corporation Information
6.5.2 Naia Pharmaceuticals Description and Business Overview
6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.5.5 Naia Pharmaceuticals Recent Developments/Updates
6.6 Nutrinia
6.6.1 Nutrinia Corporation Information
6.6.2 Nutrinia Description and Business Overview
6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.6.5 Nutrinia Recent Developments/Updates
6.7 OxThera
6.6.1 OxThera Corporation Information
6.6.2 OxThera Description and Business Overview
6.6.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.7.5 OxThera Recent Developments/Updates
6.8 Sancilio Pharmaceuticals
6.8.1 Sancilio Pharmaceuticals Corporation Information
6.8.2 Sancilio Pharmaceuticals Description and Business Overview
6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
6.9 Zealand Pharma
6.9.1 Zealand Pharma Corporation Information
6.9.2 Zealand Pharma Description and Business Overview
6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio
6.9.5 Zealand Pharma Recent Developments/Updates
7 Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Analysis
7.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
7.4 Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Short Bowel Syndrome (SBS) Drugs Distributors List
8.3 Short Bowel Syndrome (SBS) Drugs Customers
9 Short Bowel Syndrome (SBS) Drugs Market Dynamics
9.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
9.2 Short Bowel Syndrome (SBS) Drugs Market Drivers
9.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
9.4 Short Bowel Syndrome (SBS) Drugs Market Restraints
10 Global Market Forecast
10.1 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Type (2023-2028)
10.2 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Sale Channel
10.2.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2023-2028)
10.2.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2023-2028)
10.3 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
